Quantum Biopharma (QNTM) Current Leases (2019 - 2026)
Quantum Biopharma (QNTM) reported Current Leases of $83991.0 for Q1 2026, up 137.54% on a YoY basis from $35358.0 in Q1 2025, and down 18.59% sequentially from $103165.0 in Q4 2025.
Quantum Biopharma (QNTM) Current Leases (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Current Leases data on file, last reported at $83991.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 137.54% year-over-year to $83991.0; the trailing twelve-month figure through Mar 2026 stood at $83991.0 (up 137.54% YoY), and the FY2025 full-year result was $103165.0, up 91.83% from the prior year.
- Current Leases eased to $83991.0 in Q1 2026, from $103165.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $198273.0 in Q3 2022 to a low of $9634.0 in Q2 2024.
- A 5-year average of $111533.3 and a median of $107202.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases tumbled 91.01% in 2024 and soared 1525.2% in 2025, its largest moves.
- Tracing QNTM's Current Leases over 5 years: stood at $177870.0 in 2022, then tumbled by 64.97% to $62308.0 in 2023, then slipped by 13.69% to $53780.0 in 2024, then surged by 91.83% to $103165.0 in 2025, then dropped by 18.59% to $83991.0 in 2026.
- Business Quant data shows QNTM's Current Leases at $83991.0 in Q1 2026, $103165.0 in Q4 2025, and $151798.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 83,991.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,991.00 |
| Dec 31, 2025 | 103,165.00 |
| Sep 30, 2025 | 151,798.00 |
| Jun 30, 2025 | 156,572.00 |
| Mar 31, 2025 | 35,358.00 |
| Dec 31, 2024 | 53,780.00 |
| Sep 30, 2024 | 72,475.00 |
| Jun 30, 2024 | 9,634.00 |
| Sep 30, 2023 | 62,308.00 |
| Jun 30, 2023 | 107,202.00 |
| Mar 31, 2023 | 141,702.00 |
| Dec 31, 2022 | 177,870.00 |
| Sep 30, 2022 | 198,273.00 |
| Jun 30, 2022 | 158,976.00 |
| Mar 31, 2022 | 159,895.00 |
| Dec 31, 2021 | 124,311.00 |
| Sep 30, 2021 | 50,126.00 |
| Jun 30, 2021 | 61,626.00 |
| Mar 31, 2021 | 70,513.00 |
| Dec 31, 2020 | 46,842.00 |